头孢曲松钠注射液致透析患者抗生素脑病3例分析

doi:10.19803/j.1672-8629.2022.03.24

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (3): 336-338.
DOI: 10.19803/j.1672-8629.2022.03.24

头孢曲松钠注射液致透析患者抗生素脑病3例分析

朱旭婷¹, 任佳¹, 杭永付²

¹江南大学附属医院药学部,江苏无锡 214041;
²苏州大学附属第一医院药学部,江苏苏州 215006

收稿日期:2020-05-09 出版日期:2022-03-15 发布日期:2022-03-16
作者简介:朱旭婷,女,硕士,医院药学。

Three cases of antibiotic encephalopathy caused by ceftriaxone sodium injection in dialysis patients

ZHU Xuting¹, REN Jia¹, HANG Yongfu²

¹Department of Pharmacy, the Affiliated Hospital of Jiangnan University, Wuxi Jiangsu 214041, China;
²Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou Jiangsu 215006, China

Received:2020-05-09 Online:2022-03-15 Published:2022-03-16

摘要/Abstract

摘要： 目的分析头孢曲松钠在肾内科透析患者中引起的抗生素脑病,为特殊人群临床用药提供参考。方法临床药师根据国家药品不良反应中心制定的关联性评价标准及诺氏药物不良反应评估量表分析了3例由头孢曲松钠引起精神异常症状的透析患者,并对其进行因果关系评价。结果 3例患者病程中使用头孢曲松钠后,均出现了不同程度的精神异常症状,停用抗菌药物并予对症处理后,精神症状均得到缓解。结论对于肾功能不全患者,使用头孢菌素类抗菌药物需谨慎,特别是说明书未收载的精神异常症状,偶有发生,需引起医护人员重视,加强临床观察。

关键词: 头孢曲松钠, 慢性肾功能不全, 透析, 抗生素脑病

Abstract: Objective To analyze antibiotic encephalopathy caused by ceftriaxone sodium in patients under renal dialysis, and to provide reference for clinical drug use among a special population. Methods The clinical data on three dialysis patients with psychiatric symptoms caused by ceftriaxone sodium was analyzed by a clinical pharmacist according to the correlation evaluation criteria established by the National Center for Adverse Drug Reactions and the Naranjo's Adverse Drug Evaluation Scale. Results After ceftriaxone sodium was used, all the three patients experienced different degrees of psychotic symptoms. But when antibacterial drugs were discontinued and symptomatic treatment started, these mental symptoms were alleviated. Conclusion For patients with renal insufficiency, cephalosporins should be used with caution to prevent psychiatric abnormalities that are not included in the instructions, which occasionally occur and need to be taken seriously by clinicians.

Key words: ceftriaxone sodium, chronic kidney disease, dialysis, antibiotic encephalopathy

中图分类号:

R994.11

朱旭婷, 任佳, 杭永付. 头孢曲松钠注射液致透析患者抗生素脑病3例分析[J]. 中国药物警戒, 2022, 19(3): 336-338.

ZHU Xuting, REN Jia, HANG Yongfu. Three cases of antibiotic encephalopathy caused by ceftriaxone sodium injection in dialysis patients[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 336-338.

参考文献

[1] TANG L,YIN T.Pharmaceutical analysis and care for antibiotic encephalopathy caused by cefoselis in uremic patients[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2016(17): 1614-1616.
[2] WANG X, WANG YR, YAN N, et al.Piperacillin/tazobactam-induced antibiotic encephalopathy in a patient with chronic renal insufficiency[J]. Chinese Pharmacist(中国药师), 2018, 21(2): 311-312.
[3] Sanford. Fever(热病)[M]. 48th ed. Beijing: Peking Union Medical College Press, 2019.
[4] NARANJO CA, SHEAR NH, LANCTOT KL.Advances in the diagnosis of adverse drug reactions[J]. Journal of Clinical Pharmacology,1992, 32(10): 897-904.
[5] MOU P, LIAO CB, XU SY, et al.Analysis of pharmacists using the Naranjo's evaluation scale to diagnose adverse drug reaction cases[J]. J Mod Med Health(现代医药卫生), 2018, 34(20): 3262-3264.
[6] LAMOTH F, BUCLIN T, PASCUAL A, et al.High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function[J]. Antimicrobial Agents and Chemotherapy, 2010, 54(10): 4360-4367.
[7] REN FY, LI YZ, ZHANG DS.One case of psychiatric symptoms caused by intravenous infusion of ceftriaxone sodium(fanshengshufu)[J]. Journal of Pharmaceutical Practice(药学实践杂志), 2006(1): 45.
[8] LIU DL.A case of hallucinogenic psychosis caused by ceftriaxone sodium[J]. Chin J Geriatr(中华老年医学杂志), 2004, 23(6): 413.
[9] ZHANG MX, HUANG J.Mental disorders during treatment with ceftriaxone/sulbactam injection[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2004, 6(3): 199-200.
[10] FAN M.Literature analysis on the adverse reactions of cephalos-porins[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2012, 9(2): 119-123.
[11] WANG GL.Clinical analysis of neuropsychiatric symptoms in patients with chronic renal failure caused by cephalosporin antibiotics[J]. China Clin Prac Med(中国临床实用医学), 2010, 4(1): 197-198.
[12] ZHENG CZ, SHU YB, Li CP.Clinical analysis of cephalosporin encephalopathy in 28 patients with chronic renal failure[J]. Anhui Medical Journal(安徽医学), 2014(2): 149-151.
[13] GRILL MF, MAGANTI RK.Neurotoxic effects associated with antibiotic use: management considerations[J]. British Journal of Clinical Pharmacology, 2011, 72(3): 381-393.
[14] Endocrinology and Metabolism Branch of Chinese Association of Geriatric, Research Committee of Clinical Toxicology of Chinese Society of Toxicology. Expert consensus on risk management of polypharmacy in elderly[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(10): 55-68.
[15] JIANG MH, XU YP, HAN ZW, et al.Risk factors for antibiotic encephalopathy in peritoneal dialysis patients[J]. Chinese Journal of Microcirculation(微循环学杂志), 2019, 29(1): 73-76.
[16] REN Q.Clinical analysis of patients with antibiotic encephalopathy induced by cephalosporins[J]. Journal of China Prescription Drug(中国处方药), 2019, 17(7): 53-54.
[17] CHEN TA, LIU X, LIANG Y.Analysis on characteristics of antibacterial use in inpatients with chronic kidney disease[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(9): 42-46.
[18] ZHANG RK, DONG SX, ZHANG ZP.One case of mental disorder caused by ceftriaxone sodium in patient with renal insufficiency[J]. Mod Diagn Treat(现代诊断与治疗), 2014(9): 2133.

头孢曲松钠注射液致透析患者抗生素脑病3例分析

Three cases of antibiotic encephalopathy caused by ceftriaxone sodium injection in dialysis patients

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

[1]	张志文, 唐莉华. 疑似注射用哌拉西林钠舒巴坦钠致尿毒症血液透析患者精神异常1例分析[J]. 中国药物警戒, 2023, 20(5): 588-590.
[2]	陈诚, 邓莉, 刘松青, 杜倩, 奚鑫. 重庆市2015年至2020年药源性过敏性休克报告分析[J]. 中国药物警戒, 2023, 20(4): 460-464.
[3]	范雷雷, 杨静, 肖倩倩, 高东学, 曲素萍. 卡维地洛与美托洛尔对血液透析患者心肌梗死及心功能影响的对比研究[J]. 中国药物警戒, 2022, 19(12): 1338-1343.
[4]	王芳, 李永辉, 郭瑞锋, 邱志宏, 刘欣欣. 376例注射用头孢曲松钠不良反应的文献分析[J]. 中国药物警戒, 2019, 16(5): 289-292.
[5]	杨青, 蔡宁, 袁菱, 孙彬, 金鑫. 1例腹膜透析相关性腹膜炎患者实施万古霉素血药浓度监测的药学实践[J]. 中国药物警戒, 2019, 16(11): 683-687.
[6]	魏芬芳, 孙怡园, 杨悦. 注射用头孢曲松钠不良反应的Meta分析[J]. 中国药物警戒, 2016, 13(6): 351-358.
[7]	关尚为,郑婷婷,张威. 从罗氏芬说明书变更看头孢曲松钠与含钙产品的合理使用[J]. 中国药物警戒, 2015, 12(4): 245-248.
[8]	刘翠丽,刘太雨,田春华 . 注射用头孢曲松钠临床使用中常见问题刍议[J]. 中国药物警戒, 2013, 10(8): 497-500.
[9]	王静芬，苏利群. 头孢曲松钠致过敏性休克97例文献分析[J]. 中国药物警戒, 2012, 9(3): 178-180.
[10]	肖育华, 王宏, 杨丽君, 卢淑棠, 梁彦, 邓剑雄. 广东省透析装置不良事件重点监测报告分析[J]. 中国药物警戒, 2012, 9(12): 734-736.
[11]	张敏, 赵燕, 丁红. 浅析血液透析器的风险[J]. 中国药物警戒, 2012, 9(10): 605-606.